Specific Management of Post-Chikungunya Rheumatic Disorders: A Retrospective Study of 159 Cases in Reunion Island from 2006-2012

PLoS Neglected Tropical Diseases

Volumn 9, Issue 3, 2015, Pages

  Javelle, Emilie ^a   Ribera, Anne ^b   Degasne, Isabelle ^c   Gaüzère, Bernard Alex ^c   Marimoutou, Catherine ^d   Simon, Fabrice ^a  

^a LAVERAN MILITARY TEACHING HOSPITAL   (France)

^b Private Rheumatology Office   (France)

^c UNIVERSITÉ DE LA RÉUNION   (France)

^d Epidemiologic and Public Health Military Center   (France)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

ADULT; AGED; ARTHRALGIA; ARTICLE; BONE RADIOGRAPHY; CHIKUNGUNYA; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE TRANSMISSION; EVIDENCE BASED PRACTICE; FEMALE; HUMAN; INFORMATION PROCESSING; KNEE DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; POLYARTHRITIS; RETROSPECTIVE STUDY; RHEUMATOID NODULE; SPONDYLARTHRITIS; TREATMENT PLANNING; CHRONIC DISEASE; COMPLICATION; EPIDEMIOLOGY; MIDDLE AGED; REUNION; RHEUMATIC DISEASES; TIME FACTOR;

ADULT; CHIKUNGUNYA FEVER; CHRONIC DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; REUNION; RHEUMATIC DISEASES; TIME FACTORS;

EID: 84928792826     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003603     Document Type: Article

References (60)

1. Robinson MC, An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952–53. I. Clinical features. Trans R Soc Trop Med Hyg. 1955;49(1):28–32. 14373834
2. Lumsden WH, An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952–53. II. General description and epidemiology. Trans R Soc Trop Med Hyg. janv 1955;49(1):33–57. 14373835
3. Suhrbier A, Jaffar-Bandjee M-C, Gasque P, Arthritogenic alphaviruses—an overview. Nat Rev Rheumatol. 2012;8(7):420–9. doi: 10.1038/nrrheum.2012.64 22565316
4. Leparc-Goffart I, Nougairede A, Cassadou S, Prat C, de Lamballerie X, Chikungunya in the Americas. Lancet. 2014;383(9916):514. doi: 10.1016/S0140-6736(14)60185-9 24506907
5. Van Bortel W, Dorleans F, Rosine J, Blateau A, Rousset D, et al. Chikungunya outbreak in the Caribbean region, December 2013 to March 2014, and the significance for Europe. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2014;19(13).
6. Kuehn BM, Chikungunya virus transmission found in the United States: US health authorities brace for wider spread. JAMA. 2014;312(8):776–7. doi: 10.1001/jama.2014.9916 25120064
7. Bonizzoni M, Gasperi G, Chen X, James AA, The invasive mosquito species Aedes albopictus: current knowledge and future perspectives. Trends Parasitol. 2013
8. Simon F, Javelle E, Oliver M, Leparc-Goffart I, Marimoutou C, Chikungunya virus infection. Curr Infect Dis Rep. 2011;13(3):218–28. doi: 10.1007/s11908-011-0180-1 21465340
9. Fourie ED, Morrison JG, Rheumatoid arthritic syndrome after chikungunya fever. South Afr Med J Suid-Afr Tydskr Vir Geneeskd. 1979;56(4):130–2. 494034
10. Brighton SW, Prozesky OW, de la Harpe AL, Chikungunya virus infection. A retrospective study of 107 cases. South Afr Med J Suid-Afr Tydskr Vir Geneeskd. 1983;63(9):313–5.
11. Brighton SW, Simson IW, A destructive arthropathy following Chikungunya virus arthritis—a possible association. Clin Rheumatol. 1984;3(2):253–8. 6088159
12. Borgherini G, Poubeau P, Jossaume A, Gouix A, Cotte L, et al. Persistent arthralgia associated with chikungunya virus: a study of 88 adult patients on reunion island. Clin Infect Dis Off Publ Infect Dis Soc Am. 2008;47(4):469–75.
13. Sissoko D, Malvy D, Ezzedine K, Renault P, Moscetti F, et al. Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period. PLoS Negl Trop Dis. 2009;3(3):e389. doi: 10.1371/journal.pntd.0000389 19274071
14. Chopra A, Anuradha V, Ghorpade R, Saluja M, Acute Chikungunya and persistent musculoskeletal pain following the 2006 Indian epidemic: a 2-year prospective rural community study. Epidemiol Infect. 2012;140(5):842–50. doi: 10.1017/S0950268811001300 21767452
15. Manimunda SP, Vijayachari P, Uppoor R, Sugunan AP, Singh SS, et al. Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging. Trans R Soc Trop Med Hyg. juin 2010;104(6):392–9. doi: 10.1016/j.trstmh.2010.01.011 20171708
16. Mathew AJ, Goyal V, George E, Thekkemuriyil DV, Jayakumar B, et al. Rheumatic-musculoskeletal pain and disorders in a naïve group of individuals 15 months following a Chikungunya viral epidemic in south India: a population based observational study. Int J Clin Pract. 2011;65(12):1306–12. doi: 10.1111/j.1742-1241.2011.02792.x 22093538
17. Taubitz W, Cramer JP, Kapaun A, Pfeffer M, Drosten C, Dobler G, et al. Chikungunya Fever in Travelers: Clinical Presentation and Course. Clin Infect Dis. 2007;45(1):e1–4. 17554689
18. Moro ML, Grilli E, Corvetta A, Silvi G, Angelini R, et al. Long-term chikungunya infection clinical manifestations after an outbreak in Italy: a prognostic cohort study. J Infect. 2012;65(2):165–72. doi: 10.1016/j.jinf.2012.04.005 22522292
19. Mizuno Y, Kato Y, Takeshita N, Ujiie M, Kobayashi T, et al. Clinical and radiological features of imported chikungunya fever in Japan: a study of six cases at the National Center for Global Health and Medicine. J Infect Chemother Off J Jpn Soc Chemother. 2011;17(3):419–23.
20. Kularatne SAM, Weerasinghe SC, Gihan C, Wickramasinghe S, Dharmarathne S, et al. Epidemiology, clinical manifestations, and long-term outcomes of a major outbreak of chikungunya in a hamlet in sri lanka, in 2007: a longitudinal cohort study. J Trop Med. 2012:639178. doi: 10.1155/2012/639178 22496701
21. Schilte C, Staikowsky F, Staikovsky F, Couderc T, Madec Y, et al. Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study. PLoS Negl Trop Dis. 2013;7(3):e2137. doi: 10.1371/journal.pntd.0002137 23556021
22. Essackjee K, Goorah S, Ramchurn SK, Cheeneebash J, Walker-Bone K, Prevalence of and risk factors for chronic arthralgia and rheumatoid-like polyarthritis more than 2 years after infection with chikungunya virus. Postgrad Med J. 2013;89(1054):440–7. doi: 10.1136/postgradmedj-2012-131477 23645664
23. Waymouth HE, Zoutman DE, Towheed TE, Chikungunya-related arthritis: Case report and review of the literature. Semin Arthritis Rheum. 2013;43(2):273–8. doi: 10.1016/j.semarthrit.2013.03.003 23608542
24. Marimoutou C, Vivier E, Oliver M, Boutin J- P, Simon F, Morbidity and impaired quality of life 30 months after chikungunya infection: comparative cohort of infected and uninfected French military policemen in Reunion Island. Medicine (Baltimore). 2012;91(4):212–9. doi: 10.1097/MD.0b013e318260b604 22732952
25. Chopra A, Saluja M, Venugopalan A, Chloroquine effectiveness and inflammatory cytokine response in early persistent post chikungunya musculoskeletal pain and arthritis. Arthritis Rheum. 2013 66(2):319–26.
26. Ravichandran R, Manian M, Ribavirin therapy for Chikungunya arthritis. J Infect Dev Ctries. 2008;2(2):140–2. 19738340
27. De Lamballerie X, Boisson V, Reynier J- C, Enault S, Charrel RN, et al. On chikungunya acute infection and chloroquine treatment. Vector Borne Zoonotic Dis Larchmt N. 2008;8(6):837–9. doi: 10.1089/vbz.2008.0049 18620511
28. Delogu I, de Lamballerie X, Chikungunya disease and chloroquine treatment. J Med Virol. 2011;83(6):1058–9. doi: 10.1002/jmv.22019 21503920
29. Ribéra A, Degasne I, Jaffar Bandjee MC, Gasque P, Chronic rheumatic manifestations following chikungunya virus infection: clinical description and therapeutic considerations]. Médecine Trop Rev Corps Santé Colon. 2012;72 Spec No:83–5.
30. Ganu MA, Ganu AS, Post-chikungunya chronic arthritis—our experience with DMARDs over two year follow up. J Assoc Physicians India. 2011;59:83–6. 21751641
31. Bouquillard E, Combe B, A report of 21 cases of rheumatoid arthritis following Chikungunya fever. A mean follow-up of two years. Jt Bone Spine Rev Rhum. 2009;76(6):654–7. doi: 10.1016/j.jbspin.2009.08.005 19945329
32. Hoarau J-J, Jaffar Bandjee M-C, Krejbich Trotot P, Das T, Li-Pat-Yuen G, et al. Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response. J Immunol Baltim Md. 2010;184(10):5914–27. doi: 10.4049/jimmunol.0900255 20404278
33. Sissoko D, Ezzedine K, Moendandzé A, Giry C, Renault P, Malvy D, Field evaluation of clinical features during chikungunya outbreak in Mayotte, 2005–2006. Trop Med Int Health TM IH. 2010;15(5):600–7.
34. Gérardin P, Fianu A, Michault A, Mussard C, Boussaïd K, et al. Predictors of Chikungunya rheumatism: a prognostic survey ancillary to the TELECHIK cohort study. Arthritis Res Ther. 2013;15(1):R9. doi: 10.1186/ar4137 23302155
35. Gaujoux-Viala C, Gossec L, Cantagrel A, Dougados M, Fautrel B, et al. Recommendations of the French Society for Rheumatology for managing rheumatoid arthritis. Jt Bone Spine Rev Rhum. 2014;81(4):287–97. doi: 10.1016/j.jbspin.2014.05.002 24986683
36. Wendling D, Lukas C, Paccou J, Claudepierre P, Carton L, et al. Recommendations of the French Society for Rheumatology (SFR) on the everyday management of patients with spondyloarthritis. Jt Bone Spine Rev Rhum. 2014;81(1):6–14.
37. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569–81. doi: 10.1002/art.27584 20872595
38. Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum. 1991;34(10):1218–27. 1930310
39. Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum. 2008;59(6):762–84. doi: 10.1002/art.23721 18512708
40. Brighton SW, Chloroquine phosphate treatment of chronic Chikungunya arthritis. An open pilot study. South Afr Med J Suid-Afr Tydskr Vir Geneeskd. 1984;66(6):217–8. 6087474
41. Narsimulu G, Prabhu N, Post-chikungunya chronic arthritis. J Assoc Physicians India. 2011;59:81. 21751640
42. De Chazournes P, Chikungunya on Reunion Island. Experience, opinion, and proposals of general practitioners: poorly understood symptoms, lack of treatment protocol, exaggerated sequels, neglected players]. Médecine Trop Rev Corps Santé Colon. 2012;72 Spec No:72–5.
43. Pincus T, Yazici Y, Sokka T, Aletaha D, Smolen JS, Methotrexate as the « anchor drug » for the treatment of early rheumatoid arthritis. Clin Exp Rheumatol. 2003;21(5 Suppl 31):S179–85. 14969073
44. Chopra A, Anuradha V, Lagoo-Joshi V, Kunjir V, Salvi S, Saluja M, Chikungunya virus aches and pains: an emerging challenge. Arthritis Rheum. 2008;58(9):2921–2. doi: 10.1002/art.23753 18759351
45. Shakiba Y, Koopah S, Jamshidi AR, Amirzargar AA, Massoud A, et al. Anti-cyclic citrullinated Peptide antibody and rheumatoid factor isotypes in Iranian patients with rheumatoid arthritis: evaluation of clinical value and association with disease activity. Iran J Allergy Asthma Immunol. 2014;13(3):147–56. 24659118
46. Seetharam KA, Sridevi K, Chikungunya infection: a new trigger for psoriasis. J Dermatol. 2011;38(10):1033–4. doi: 10.1111/j.1346-8138.2011.01200.x 21453316
47. Malvy D, Ezzedine K, Mamani-Matsuda M, Autran B, Tolou H, et al. Destructive arthritis in a patient with chikungunya virus infection with persistent specific IgM antibodies. BMC Infect Dis. 2009;9:200. doi: 10.1186/1471-2334-9-200 20003320
48. Chaaithanya IK, Muruganandam N, Raghuraj U, Sugunan AP, Rajesh R, et al. Chronic inflammatory arthritis with persisting bony erosions in patients following chikungunya infection. Indian J Med Res. 2014;140(1):142–5. 25222790
49. Ozden S, Huerre M, Riviere J-P, Coffey LL, Afonso PV, et al. Human muscle satellite cells as targets of Chikungunya virus infection. PloS One. 2007;2(6):e527. 17565380
50. McCarty DJ O’ Duffy JD, Pearson L, Hunter JB, Remitting seronegative symmetrical synovitis with pitting edema. RS3PE syndrome. JAMA J Am Med Assoc. 1985;254(19):2763–7.
51. Mylonas AD, Harley D, Purdie DM, Pandeya N, Vecchio PC, et al. Corticosteroid therapy in an alphaviral arthritis. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis. 2004;10(6):326–30.
52. Watson DA, Ross SA, Corticosteroids for the complications of Ross River virus infection. Med J Aust. 1998;168(2):92. 9469192
53. De Andrade DC, Jean S, Clavelou P, Dallel R, Bouhassira D, Chronic pain associated with the Chikungunya Fever: long lasting burden of an acute illness. BMC Infect Dis. 2010;10:31. doi: 10.1186/1471-2334-10-31 20170492
54. Pincus T, Yazici Y, Bergman M, A practical guide to scoring a Multi-Dimensional Health Assessment Questionnaire (MDHAQ) and Routine Assessment of Patient Index Data (RAPID) scores in 10–20 seconds for use in standard clinical care, without rulers, calculators, websites or computers. Best Pract Res Clin Rheumatol. août 2007;21(4):755–87.
55. Pincus T, Castrejón I, MDHAQ/RAPID3 scores: quantitative patient history data in a standardized « scientific » format for optimal assessment of patient status and quality of care in rheumatic diseases. Bull NYU Hosp Jt Dis. 2011;69(3):201–14. 22035430
56. Pincus T, Are patient questionnaire scores as « scientific » as laboratory tests for rheumatology clinical care? Bull NYU Hosp Jt Dis. 2010;68(2):130–9. 20632989
57. Ray P, Ratagiri VH, Kabra SK, Lodha R, Sharma S, et al. Chikungunya infection in India: results of a prospective hospital based multi-centric study. PloS One. 2012;7(2):e30025. doi: 10.1371/journal.pone.0030025 22363413
58. Nakaya HI, Gardner J, Poo Y- S, Major L, Pulendran B, Suhrbier A, Gene profiling of Chikungunya virus arthritis in a mouse model reveals significant overlap with rheumatoid arthritis. Arthritis Rheum. 2012;64(11):3553–63. doi: 10.1002/art.34631 22833339
59. Kaur P, Chu JJH, Chikungunya virus: an update on antiviral development and challenges. Drug Discov Today. 2013;18(19–20):969–83.
60. Ortiz Z, Shea B, Suarez Almazor M, Moher D, Wells G, Tugwell P, Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. Cochrane Database Syst Rev. 2000;(2):CD000951. 10796393